Evidence map›Paper›PMID 39658671›Full record

ReviewSurgical endoscopy2025

Which is the best timing for performing a cholecystectomy after percutaneous cholecystostomy?

Antonio Pesce, Camilo Ramírez-Giraldo

Abstract readReview
PubMed Publisher
In one paragraph

Review in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Observational
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Antonio PesceDepartment of Surgery, Azienda Unità Sanitaria Locale Ferrara, University of Ferrara, Via Valle Oppio, 2 - 44023, Lagosanto, FE, Italy.
Camilo Ramírez-GiraldoHospital Universitario Mayor - Méderi, Calle 24 #29 - 45, Bogotá, Colombia. ramirezgiraldocamilo@gmail.com.ORCID 0000-0002-1929-2299

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLaparoscopic cholecystectomy is the gold standard for managing acute cholecystitis. However, in high-risk surgical patients, percutaneous cholecystostomy is frequently used either as a bridge to surgery or as definitive treatment. When employed as a bridge to surgery, the optimal timing for laparoscopic cholecystectomy after cholecystostomy remains unclear.

methodsA critical review of the literature was conducted, focusing particularly on the article published by Spaniolas, et al., presented at SAGES 2024, to evaluate the optimal timing for performing laparoscopic cholecystectomy after a cholecystostomy, according to the available evidence.

resultsThe available literature was found to be limited. The timing thresholds vary across studies, preventing a pooled evaluation of the effect size. The study by Spaniolas, et al. has several limitations, including the exclusion of subtotal cholecystectomies from the composite endpoint and the introduction of implausible variables in the logistic regression model.

conclusionIdeally, the procedure should be performed when it is least technically demanding, minimizing the need for rescue procedures (such as subtotal cholecystectomy, antegrade cholecystectomy, or conversion to open surgery) and reducing complications. This topic is increasingly relevant in clinical practice. However, the current scientific evidence remains limited.

Indexed as

Cholecystectomy, LaparoscopicCholecystitis, AcuteCholecystostomyHumansPostoperative ComplicationsTime FactorsTime-to-TreatmentAcute cholecystitisCholecystectomyCholecystostomyInterval cholecystectomyPercutaneous gallbladder drainage

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.